Hannan Edward L, Wu Chuntao, Smith Craig R, Higgins Robert S D, Carlson Russell E, Culliford Alfred T, Gold Jeffrey P, Jones Robert H
State University of New York at Albany, Department of Health Policy, Management, and Behavior, One University Place, Rensselaer, NY 12144, USA.
Circulation. 2007 Sep 4;116(10):1145-52. doi: 10.1161/CIRCULATIONAHA.106.675595. Epub 2007 Aug 20.
Off-pump coronary artery bypass graft surgery (OPCAB) has been performed for many years, but its use is increasing in frequency, and it remains an open question whether OPCAB is associated with better outcomes than on-pump coronary artery bypass graft (CABG) surgery.
New York State patients who underwent either OPCAB with median sternotomy (13 889 patients) or on-pump CABG surgery (35 941 patients) between 2001 and 2004 were followed up via New York databases. Short- and long-term outcomes were compared after adjustment for patient risk factors and after patients were matched on the basis of significant predictors of type of CABG surgery. OPCAB had a significantly lower inpatient/30-day mortality rate (adjusted OR 0.81, 95% confidence interval [CI] 0.68 to 0.97), lower rates for 2 perioperative complications (stroke: adjusted OR 0.70, 95% CI 0.57 to 0.86; respiratory failure: adjusted OR 0.80, 95% CI 0.68 to 0.93), and a higher rate of unplanned operation in the same admission (adjusted OR 1.47, 95% CI 1.01 to 2.15). In the matched samples, no difference existed in 3-year mortality (hazard ratio 1.08, 95% CI 0.96 to 1.22), but OPCAB patients had higher rates of subsequent revascularization (hazard ratio 1.55, 95% CI 1.33 to 1.80). The 3-year OPCAB and on-pump survival rates for matched patients were 89.4% and 90.1%, respectively (P=0.20). For freedom from subsequent revascularization, the respective rates were 89.9% and 93.6% (P<0.0001).
OPCAB is associated with lower in-hospital mortality and complication rates than on-pump CABG, but long-term outcomes are comparable, except for freedom from revascularization, which favors on-pump CABG.
非体外循环冠状动脉搭桥手术(OPCAB)已开展多年,但其应用频率正在增加,OPCAB是否比体外循环冠状动脉搭桥(CABG)手术具有更好的预后仍是一个悬而未决的问题。
通过纽约数据库对2001年至2004年间在纽约州接受正中胸骨切开术的OPCAB(13889例患者)或体外循环CABG手术(35941例患者)的患者进行随访。在对患者风险因素进行调整后,以及在根据CABG手术类型的显著预测因素对患者进行匹配后,比较短期和长期预后。OPCAB的住院/30天死亡率显著较低(调整后的OR为0.81,95%置信区间[CI]为0.68至0.97),2种围手术期并发症发生率较低(中风:调整后的OR为0.70,95%CI为0.57至0.86;呼吸衰竭:调整后的OR为0.80,95%CI为0.68至0.93),且同一住院期间计划外手术的发生率较高(调整后的OR为1.47,95%CI为1.01至2.15)。在匹配样本中,3年死亡率无差异(风险比为1.08,95%CI为0.96至1.22),但OPCAB患者后续血管重建的发生率较高(风险比为1.55,95%CI为1.33至1.80)。匹配患者的3年OPCAB和体外循环生存率分别为89.4%和90.1%(P=0.20)。对于无后续血管重建,相应的发生率分别为89.9%和93.6%(P<0.0001)。
与体外循环CABG相比,OPCAB与较低的院内死亡率和并发症发生率相关,但长期预后相当,除了血管重建情况,体外循环CABG更具优势。